Neudle.com: "biologic markers"

Differential
(Click to cross reference)

acetylcholine receptor antibody, ganglionic

acquired immunodeficiency syndrome

acromegaly

aducanumab

adverse drug reaction

Alzheimer's disease, age of onset

Alzheimer's disease, diagnosis of

Alzheimer's disease, early onset

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, incidence

Alzheimer's disease, misdiagnosis

Alzheimer's disease, pathogenesis

Alzheimer's disease, preclinical

Alzheimer's disease, risk factors in

Alzheimer's disease, treatment of

amyloid angiopathy, cerebral

amyloid angiopathy, cerebral, inflammatory type

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid imaging

amyloid plaques

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anatomy of

aneurysm, intracranial, familial

aortic valve, lesion of

aphasia

aphasia, logopenic, progressive

aphasia, progressive, non-fluent

aphasia, progressive, primary

apolipoprotein E

apraxia

apraxia of eyelid opening

arteritis, temporal

arthralgia

artificial intelligence

astrocytoma

asymptomatic

ataxia

ataxia telangiectasia

autoimmune GFAP astrocytopathy

autonomic dysfunction

basal ganglia, lesion of

BAT score

behavioral disorder

behavioral disorder, acute

beta 2-microglobulin, cerebrospinal fluid

calcification, intracranial

callosal angle

cancer associated hypercoagulation

cancer, cerebrovascular accident complicating patients with

carcinoembryonic antigen

carcinoembryonic antigen, cerebrospinal fluid

CAT scan, emission, abnormal

CAT scan, fluid-blood level

CAT scan, hypodensity sign

cavernous sinus, metastasis to

CD4 counts

central hypoventilation

central vein sign

cerebellar ataxia, autosomal recessive

cerebellar ataxia, hereditary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellum, disease of

cerebral edema, vasogenic

cerebral embolism

cerebral embolism, cardiac origin

cerebral infarction

cerebral vasculature

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, absorption

cerebrospinal fluid, B-glucuronidase

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, cytology, false negative

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, enzymes in

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, polyamines

cerebrospinal fluid, putrescine

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, bilateral

cerebrovascular accident, multiple

cerebrovascular accident, pathophysiology

cerebrovascular accident, recurrent

cerebrovascular accident, three territory involvement

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, volume

chemotherapy, CNS treatment and complications with

children

chorea

choriocarcinoma

chronic traumatic encephalopathy

Clinical Pathologic Conference(C.P.C.)

cognition

collapsin response mediator protein 5 IgG

controversies in neurology

Cornelia de Lange syndrome

cortical infarction

cost

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

Cushing's syndrome

D-dimer

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

dementia, early detection

dementia, frontotemporal

dementia, prevention of

dementia, screening for

dementia, subcortical

dementia, treatment of

depression

developmental milestones, loss of

dexamethasone suppression test

diabetes insipidus

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diagnostic criteria

differential diagnosis

disability, neurological

disease modifying agents

electroencephalogram, abnormalities of

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, paraneoplastic

encephalomyelitis

encephalopathy

endocarditis

endocarditis, marantic

epidemiology of neurology

Epstein-Barr virus

evidence-based research

executive dysfunction

exercise

eye movement, disorders of

fibrinolytic agents, intra-arterial local infusion

florbetapir

fluorescene in situ hybridization

follicle stimulating hormone

gaze palsy, supranuclear

genetic neurologic disorders

glucosephosphate isomerase

gray matter

growth hormone

growth retardation

Guillain Barre syndrome

head injury

head injury, mild

head injury, repetitive

head injury, return to play following

headache

hemifacial spasm

hemiparesis

hemosiderosis of CNS, superficial

heralding manifestation

herpes virus

herpes virus infection

human chorionic gonadotropin, elevated

human immunodeficiency virus type 1

Huntington's chorea

hydrocephalus

hydrocephalus, normal pressure

hypercoagulable state

immunosuppressive agents

immunotherapy

incoordination

insomnia

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracerebral hemorrhage, progression of

intracerebral hemorrhage, volume

intracranial pressure, increased

intrathecal chemotherapy

intrathecal treatment of meningitis

iron, brain

Jakob-Creutzfeldt disease

JC virus

Klinefelter's syndrome

lecanemab

leptin

leukemia, neurologic findings assoc.with

leukoencephalopathy

level of consciousness, decreased

Lewy body disease, diffuse

lymphoma involving CNS

lymphoma, primary of CNS

memory, defect of recent

memory, evaluation of

memory, impairment of

memory, impairment of, subjective

meningeal gliomatosis

meningioma

meningitis

meningitis, aseptic

meningitis, carcinomatous

meningitis, chronic

meningitis, leukemic

meningitis, lymphomatous

meningitis, noninfectious

meningoencephalitis

meningoencephalomyelitis

mental status, abnormal

methotrexate

microemboli

microhemorrhage, intracerebral

microsurgery

microsurgery, transsphenoidal

midbrain

midbrain, atrophy

midbrain, lesion of

middle cerebral artery, emboli to

middle cerebral artery, occlusion of

mild cognitive impairment

mild cognitive impairment converting to Alzheimer's disease

mimics

Mini Mental Status Examination

misdiagnosis

mitral valve vegetation

molecular genetics

molecular markers

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

mortality

movement disorder

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, automated reading

MRI, contrast enhanced

MRI, cranial nerves

MRI, diffusion tensor

MRI, diffusion weighted

MRI, field strength, high

MRI, paramagnetic effect

MRI, peripheral nerve

MRI, serial

MRI, spinal cord

MRI, spine

MRI, susceptibility weighted

MRI, volumetry

MRI, voxel-based morphometry

MRS

mucinous cancer

multiple sclerosis

multiple sclerosis, diagnosis of

multiple sclerosis, plaque

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple system atrophy

myelination of nervous system

myelitis

myelitis, autoimmune

myelitis, longitudinal

myopathy, drug-induced

myopathy, necrotizing

myopathy, necrotizing, autoimmune

myopathy, necrotizing, immune-mediated

neoplasm, intracranial with metastasis extracranially

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, treatment of

neoplasm, primary intracerebral

neoplasm, primary intracranial-treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-children

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

nerve conduction studies

neuroendocrinology

neurofilament light chain protein

neurofilaments

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica, IgG

neuron specific enolase

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, diabetic

neuroprotective agents

neurotransmitter

neutrophil extracellular traps

normal

octreotide

old age, neurology of

olfactory bulb

olfactory sulcus

opportunistic infection

opportunistic infection, CNS

opsoclonus

opsoclonus-myoclonus syndrome

optic neuritis

optic neuritis, recurrent

pain, back

paraneoplastic cerebellar degeneration

paranoia

parasomnia

Parkinson disease

Parkinson disease, atypical

Parkinson disease, classification

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, heterogeneity of

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, subtypes

Parkinsonism syndrome

pathology

patient information and support

peptides, brain

perivascular enhancement

Pittsburgh Compound B

pituitary

pituitary, adenoma

pituitary, hormones of

pituitary, microadenoma

platelet function test

pleocytosis of cerebrospinal fluid

polymerase chain reaction

polymyalgia rheumatica

polyneuropathy

posterior cortical atrophy

practice guidelines

preclinical

pretectal syndrome

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

prolactin

prolactin, elevated

prolactinoma

protein 14-3-3, cerebrospinal fluid

psychiatric problems in neurologic disorders

psychological testing

pulvinar

purkinje cell cytoplastic autoantibody

radiation encephalopathy, delayed

radiation therapy, CNS treatment and complications with

radioimmunoassay

radiotracer imaging

reading disorder, acquired

reading problem, causes of

REM sleep

remote effect of cancer on the nervous system

respirations in CNS disease

retroperitoneal mass

reversible neurologic disorder

review article

rigidity, axial

risk factors

risk factors, modification

risk stratification

saccadic eye movements

saccadic eye movements, abnormal

safety

salivation, excessive

screening

sedimentation rate, elevated

seizure

seizure, drug resistance

seizure, psychomotor-temporal lobe

shared decision making

shoulder, pain in

single photon emission computed tomography

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, biopsy

sleep apnea, obstructive

sleep pathology and physiology

smell

Smell Identification Test

somatostatin analogue

spine, metastasis to

sports medicine, neurology of

Spot sign

staggering

statin therapy

steroid therapy, CNS treatment and complications with

temporal artery, biopsy

temporal lobe

temporal lobe, atrophy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tissue plasminogen activator, intravenous

treatment of neurologic disorder

uveal melanocytic proliferation

vaginal bleeding

ventricular enlargement

viral infection

visual acuity

visual acuity, decreased, monocular

visual field defect

visual loss

visual loss, slow-unilateral

vitamin E deficiency

vocal cord paralysis

walking, difficulty with

weakness

weakness, progressive

Showing articles 0 to 50 of 532 Next >>

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Alzheimers Disease Biomarkers - Timing is Everything
NEJM 390:761-763, Mayeux,R., 2024

Clinical,Neuroimaging,and Genetic Markers in Cerebral Amyloid Angiopatny-Related Inflammation:A Systematic Review and Meta-Analusis
Stroke 54:178-188, Theodorou,A.,et al, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

Alzheimers Disease
Lancet 397:1577-1590, Scheltens, P.,et al, 2021

National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
Neurol 96:848-863, Katz, D.I.,et al, 2021

Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
AJNR 42:998-1007, Oldan, J.D.,et al, 2021

Mechanisms of Ischemic Stroke in Patients with Cancer
Ann Neurol 90:159-169, Navi, B.B.,et al, 2021

Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021

The First Examination of Diagnostic Performance of Automated Measurement of the Callosal Angle in 1856 Elderly Patients and Volunteers Indicates that 12.4% of Exams Met the Criteria for Possible Normal Pressure Hydrocephalus
AJNR 42:1942-1948, Morzage, M.,et al, 2021

Circulating DNAs, a Marker of Neutrophil Extracellular Traposis and Cancer-Related Stroke
Stroke 50:2944-2947, Bang, O.Y.,et al, 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurol 76:1035-1048, Bridel, C.,et al, 2019

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis
JAMA Neurol 76:1446-1456, Sinnecker, T.,et al, 2019

The So-Called "Bovine Aortic Arch": A Possible Biomarker for Embolic Strokes?
Neuroradiology 61:1165-1172, Syperek, A.,et al, 2019

D-dimer >2.785 �g/ml and multiple infarcts =3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients
Neurol Res 40:948-954, Wang, J.,et al, 2018

Practice Guide Update Summary: Mild Cognitive Impairment
Neurol 90:126-135, Petersen, R.C.,et al, 2018

Diagnosis of Cerebral Amyloid Angiopathy
Stroke 49:491-497, Greenberg, S.M.,et al, 2018

Predicting Intracerebral Hemorrhage Expansion With Noncontrast Computed Tomography
Stroke 49:1163-1169, Morotti, A.,et al, 2018

A 60-year-old woman with ataxia
Neurol 90:e1627-e1630, Dandapat, S.,et al, 2018

Glial Fibrillary Acidic Protein Immunoglobulin G as Biomarker of Autoimmune Astrocytopathy: Analysis of 102 Patients
Ann Neurol 81:298-309, Flanagan, E.P.,et al, 2017

Blood-based NfL - A biomarker for differential diagnosis of parkinsonian disorder
Neurol 88:930-937,922, Hansson, O.,et al, 2017

Neurofilament as a Blood Marker for Diagnosis and Monitoring of Primary Progressive Aphasias
Neurol 88:961-969, Steinacker, P.,et al, 2017

Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017

Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion
Stroke 48:1120-1125, Boulouis, G.,et al, 2017

Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017

Diagnosis and Management of Dementia with Lewy Bodies
Neurol 89:88-100, McKeith, I.G.,et al, 2017

A New Potential Biomarker for Dementia with Lewy Bodies
Neurol 89:318-326, Donadio, V.,et al, 2017

Odor Identification as a Biomarker of Preclinical AD in Older Adults at Risk
Neurol 89:327-335, Lafaille-Magnanm, M.E.,et al, 2017

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Court
JAMA Neurol 74:933-940,901, Jennings, D.,et al, 2017

Neuroimaging Changes in Menkes Disease, Part 1
AJNR 38:1850-1857, Manara, R.,et al, 2017

Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017

�-Amyloid in CSF
Neurol 88:169-176, van Etten, E.Sl.,et al, 2017

Acute Plasma Tau relates to Prolonged return to play after concussion
Neurol 88:595-602, Gill, J.,et al, 2017

Cortical Superficial Siderosis
Neurol 87:1110-1117, Shams, S.,et al, 2016

Aphasic Variant of Alzheimer Disease
Neurol 87:1337-1343, Rogalski, E.,et al, 2016

Statin-Associated Autoimmune Myopathy
NEJM 374:664-669, Mammen, A.L., 2016

A Clinical Approach to Diagnosis of Autoimmune Encephalitis
Lancet Neurol 15:391-404, Graus, F.,et al, 2016

A Clinical Approach to the Diagnosis of Traumatic Encephalopathy Syndrome
JAMA Neurol 73:743-749, Reams, N.,et al, 2016

Polymyalgia Rheumatica and Giant Cell Arteritis
JAMA 315:2442-2458, Buttgereit, F.,et al, 2016

Comparing 3T and 1.5T MRI for Mapping Hippocampal Atrophy in the Alzheimers Disease Neuroimaging Initiative
AJNR 36:653-660, Chow, N.,et al, 2015

Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015

Magnetic Resonance Neurography Detects Diabetic Neuropathy Early and with Proximal Predominance
Ann Neurol 78:939-948, Pham, M.,et al, 2015

Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014

Parkinson Disease Subtypes
JAMA 71:499-504, Thenganatt, M. & Jankovic, J., 2014

Skin Nerve (-Synuclein Deposits
Neurol 82:1362-1369, Donadio, V.,et al, 2014

Anti-HMGCR Autoantibodies in European Patients with Autoimmune Necrotizing Myopathies
Medicine 93:150-157, Allenbach, Y.,et al, 2014

Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
JAMA Neurol 71:684-692,677, Shahim, P.,et al, 2014

Predicting Alzheimer Disease with �-Amyloid Imaging: Results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing
Ann Neurol 74:905-913, Rowe, C.C.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Showing articles 0 to 50 of 532 Next >>